Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on Rose Avenue


3 Vehicles Involved in Fatal Oxnard Accident

Oxnard, CA (March 3, 2020) – One person was killed in a multi-vehicle crash in Oxnard. The fatal accident occurred on the afternoon of March 3 on Rose Avenue.

Three vehicles collided near Rio Mesa High School. Authorities arrived and found one person dead at the accident scene. Two others were critically injured and taken to a local hospital. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Oxnard

#93036


November 18, 2019

Woman Injured After Exiting Moving Vehicle on Highway 160 Near Del Paso Boulevard

Woman Hit by Car in Sacramento Accident...


April 8, 2020

1 Killed, 1 Injured in Crash on Jamacha Boulevard

Mail Truck Crashes Into España Liquor Store in Fatal Spring Valley Accident...


May 4, 2020

Woman Killed in Crash on Highway 99 and 5th Avenue

Pickup Truck, Motorcycle Collide in Fatal Sacramento Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.